Amiel Gold is an attorney and Head of Legal at the Center for Breakthrough Medicines. He is responsible for ensuring company policies and business strategies are aligned with legal implications and obligations.

Amiel Gross is a professional who has studied International Law at the Queen Mary University of London. Amiel holds a Bachelor of Arts Degree from the Southwestern University and a Doctor of Law Degree from The University of Texas School of Law. Amiel has a wide range of experience in counseling executives and senior management, negotiating complex commercial transactions, facilitating strategic alliances, or supporting a range of legal issues arising in the course for highly-regulated biotechnology business operations.

As a professional in the business, he is responsible for managing licensing deals, master services agreements, procurement contracts and intellectual property. He also works with FDA regulatory and compliance and litigation.

1. Head of Legal

   Center for Breakthrough Medicines · Jan 2021 - Present

   Multi-disciplinary life science practice focused on counseling executives and senior management, negotiating complex commercial transactions, facilitating strategic alliances and supporting a range of legal issues arising in the course of highly-regulated biotechnology business operations. Oversight responsibility and hands-on experience across array of subject matters including master services agreements, licensing deals, procurement contracts, corporate affairs, intellectual property, sponsored R&D collaborations, FDA regulatory and compliance, labor and employment, litigation, cybersecurity and privacy.

1. Doctor of Law Law

   Southwestern University · Sep 1994 - Sep 1996

2. Bachelor of Arts Degree Law

   Southwestern University · Nov 1990 - Nov 1994

3. International Law International Law

   The Queen Mary University of London · Sep 1986 - Sep 1990